Top

Published in:

Open Access 01-12-2011 | Review

Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury

Authors: Andrew D Gaudet, Phillip G Popovich, Matt S Ramer

Published in: Journal of Neuroinflammation | Issue 1/2011

Abstract

In this review, we first provide a brief historical perspective, discussing how peripheral nerve injury (PNI) may have caused World War I. We then consider the initiation, progression, and resolution of the cellular inflammatory response after PNI, before comparing the PNI inflammatory response with that induced by spinal cord injury (SCI).

In contrast with central nervous system (CNS) axons, those in the periphery have the remarkable ability to regenerate after injury. Nevertheless, peripheral nervous system (PNS) axon regrowth is hampered by nerve gaps created by injury. In addition, the growth-supportive milieu of PNS axons is not sustained over time, precluding long-distance regeneration. Therefore, studying PNI could be instructive for both improving PNS regeneration and recovery after CNS injury. In addition to requiring a robust regenerative response from the injured neuron itself, successful axon regeneration is dependent on the coordinated efforts of non-neuronal cells which release extracellular matrix molecules, cytokines, and growth factors that support axon regrowth. The inflammatory response is initiated by axonal disintegration in the distal nerve stump: this causes blood-nerve barrier permeabilization and activates nearby Schwann cells and resident macrophages via receptors sensitive to tissue damage. Denervated Schwann cells respond to injury by shedding myelin, proliferating, phagocytosing debris, and releasing cytokines that recruit blood-borne monocytes/macrophages. Macrophages take over the bulk of phagocytosis within days of PNI, before exiting the nerve by the circulation once remyelination has occurred. The efficacy of the PNS inflammatory response (although transient) stands in stark contrast with that of the CNS, where the response of nearby cells is associated with inhibitory scar formation, quiescence, and degeneration/apoptosis. Rather than efficiently removing debris before resolving the inflammatory response as in other tissues, macrophages infiltrating the CNS exacerbate cell death and damage by releasing toxic pro-inflammatory mediators over an extended period of time. Future research will help determine how to manipulate PNS and CNS inflammatory responses in order to improve tissue repair and functional recovery.

Available only for authorised users

Alfred RH, Jacobs RL: Der Welk Arm (The Withered Arm). The Iowa Orthopaedic Journal. 1986, 6: 87-89.PubMedCentral

Ober WB: Obstetrical events that shaped Western European history. Yale J Biol Med. 1992, 65: 201-210.PubMedCentralPubMed

Jain V, Sebire NJ, Talbert DG: Kaiser Wilhelm syndrome: obstetric trauma or placental insult in a historical case mimicking Erb's palsy. Med Hypotheses. 2005, 65: 185-191. 10.1016/j.mehy.2004.12.027.PubMed

Langley JN, Hashimoto M: On the suture of separate nerve bundles in a nerve trunk and on internal nerve plexuses. J Physiol. 1917, 51: 318-346.PubMedCentralPubMed

Jobe MT, Martinez SF: Peripheral Nerve Injuries. Campbell's Operative Orthopaedics. Edited by: Canale ST, Beaty JH. 2007, Mosby

Seddon H: The use of autogenous grafts for the repair of large gaps in peripheral nerves. British Journal of Surgery. 1947, 35: 151-167. 10.1002/bjs.18003513808.PubMed

Woodhall B, Beebe G: Peripheral Nerve Regeneration: A Follow-Up Study of 3,656 World War II Injuries. 1956, Washington, DC: US Government Printing Office

Abe N, Cavalli V: Nerve injury signaling. Curr Opin Neurobiol. 2008, 18: 276-283. 10.1016/j.conb.2008.06.005.PubMedCentralPubMed

Fenrich K, Gordon T: Canadian Association of Neuroscience review: axonal regeneration in the peripheral and central nervous systems--current issues and advances. Can J Neurol Sci. 2004, 31: 142-156.PubMed

10.

Shim S, Ming GL: Roles of channels and receptors in the growth cone during PNS axonal regeneration. Exp Neurol. 2010, 223: 38-44. 10.1016/j.expneurol.2009.10.001.PubMedCentralPubMed

11.

Waller A: Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philosophical Transactions of the Royal Society of London. 1850, 140: 423-429. 10.1098/rstl.1850.0021.

12.

Stoll G, Jander S, Myers RR: Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst. 2002, 7: 13-27. 10.1046/j.1529-8027.2002.02002.x.PubMed

13.

Griffin JW, George EB, Hsieh S-T, Glass JD: Axonal degeneration and disorders of the axonal cytoskeleton. The Axon: Structure, Function and Pathophysiology. Edited by: Waxman SG, Kocsis JD, Stys PK. 1995, New York: Oxford University Press, 375-390.

14.

Griffin JW, Thompson WJ: Biology and pathology of nonmyelinating Schwann cells. Glia. 2008, 56: 1518-1531. 10.1002/glia.20778.PubMed

15.

Vargas ME, Barres BA: Why is Wallerian degeneration in the CNS so slow?. Annu Rev Neurosci. 2007, 30: 153-179. 10.1146/annurev.neuro.30.051606.094354.PubMed

16.

Luttges MW, Kelly PT, Gerren RA: Degenerative changes in mouse sciatic nerves: electrophoretic and electrophysiologic characterizations. Exp Neurol. 1976, 50: 706-733. 10.1016/0014-4886(76)90039-X.PubMed

17.

Tsao JW, George EB, Griffin JW: Temperature modulation reveals three distinct stages of Wallerian degeneration. J Neurosci. 1999, 19: 4718-4726.PubMed

18.

Lubinska L: Early course of Wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res. 1977, 130: 47-63. 10.1016/0006-8993(77)90841-1.PubMed

19.

Miledi R, Slater CR: On the degeneration of rat neuromuscular junctions after nerve section. J Physiol. 1970, 207: 507-528.PubMedCentralPubMed

20.

Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP: The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 2005, 6: 6-10.1186/1471-2202-6-6.PubMedCentralPubMed

21.

Chaudhry V, Cornblath DR: Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve. 1992, 15: 687-693. 10.1002/mus.880150610.PubMed

22.

Gilliatt RW, Hjorth RJ: Nerve conduction during Wallerian degeneration in the baboon. J Neurol Neurosurg Psychiatry. 1972, 35: 335-341. 10.1136/jnnp.35.3.335.PubMedCentralPubMed

23.

George EB, Glass JD, Griffin JW: Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci. 1995, 15: 6445-6452.PubMed

24.

Sievers C, Platt N, Perry VH, Coleman MP, Conforti L: Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res. 2003, 46: 161-169. 10.1016/S0168-0102(03)00039-7.PubMed

25.

Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T: In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med. 2005, 11: 572-577. 10.1038/nm1229.PubMed

26.

Nikolaeva MA, Mukherjee B, Stys PK: Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J Neurosci. 2005, 25: 9960-9967. 10.1523/JNEUROSCI.2003-05.2005.PubMed

27.

Stirling DP, Stys PK: Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med. 2010, 16: 160-170. 10.1016/j.molmed.2010.02.002.PubMedCentralPubMed

28.

Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD: Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain. 2004, 127: 671-679.PubMed

29.

Touma E, Kato S, Fukui K, Koike T: Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice. Eur J Neurosci. 2007, 26: 3368-3381. 10.1111/j.1460-9568.2007.05943.x.PubMed

30.

Zhai Q, Wang J, Kim A, Liu Q, Watts R, Hoopfer E, Mitchison T, Luo L, He Z: Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron. 2003, 39: 217-225. 10.1016/S0896-6273(03)00429-X.PubMed

31.

Coleman MP, Freeman MR: Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci. 2010, 33: 245-267. 10.1146/annurev-neuro-060909-153248.PubMed

32.

Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S: Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci. 1989, 1: 27-33. 10.1111/j.1460-9568.1989.tb00771.x.PubMed

33.

Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP: Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci. 2010, 30: 13291-13304. 10.1523/JNEUROSCI.1189-10.2010.PubMed

34.

Perry VH, Brown MC, Tsao JW: The Effectiveness of the Gene Which Slows the Rate of Wallerian Degeneration in C57BL/Ola Mice Declines With Age. Eur J Neurosci. 1992, 4: 1000-1002. 10.1111/j.1460-9568.1992.tb00126.x.PubMed

35.

Glass JD, Brushart TM, George EB, Griffin JW: Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J Neurocytol. 1993, 22: 311-321. 10.1007/BF01195555.PubMed

36.

Conforti L, Tarlton A, Mack TG, Mi W, Buckmaster EA, Wagner D, Perry VH, Coleman MP: A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci USA. 2000, 97: 11377-11382.PubMedCentralPubMed

37.

Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP: Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci. 2001, 4: 1199-1206.PubMed

38.

Bisby MA, Chen S: Delayed wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res. 1990, 530: 117-120. 10.1016/0006-8993(90)90666-Y.PubMed

39.

Popovich PG, Horner PJ, Mullin BB, Stokes BT: A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol. 1996, 142: 258-275. 10.1006/exnr.1996.0196.PubMed

40.

Weerasuriya A, Mizisin AP: The blood-nerve barrier: structure and functional significance. Methods Mol Biol. 2011, 686: 149-173. 10.1007/978-1-60761-938-3_6.PubMed

41.

Olsson Y: Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol. 1968, 10: 26-33. 10.1007/BF00690507.PubMed

42.

Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M: GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Eur J Neurosci. 2001, 13: 2177-2182. 10.1046/j.0953-816x.2001.01596.x.PubMed

43.

Smith CE, Atchabahian A, Mackinnon SE, Hunter DA: Development of the blood-nerve barrier in neonatal rats. Microsurgery. 2001, 21: 290-297. 10.1002/micr.1055.PubMed

44.

Gray M, Palispis W, Popovich PG, van Rooijen N, Gupta R: Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J Neurosci Res. 2007, 85: 766-777. 10.1002/jnr.21166.PubMed

45.

Weerasuriya A, Hockman CH: Perineurial permeability to sodium during Wallerian degeneration in rat sciatic nerve. Brain Res. 1992, 581: 327-333. 10.1016/0006-8993(92)90727-Q.PubMed

46.

Mizisin AP, Weerasuriya A: Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol. 2011, 121: 291-312. 10.1007/s00401-010-0783-x.PubMedCentralPubMed

47.

S Ramon y Cajal: Cajal's Degeneration & Regeneration of the Nervous System. 1991, New York: Oxford University Press

48.

Campana WM: Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun. 2007, 21: 522-527. 10.1016/j.bbi.2006.12.008.PubMedCentralPubMed

49.

Lee HK, Shin YK, Jung J, Seo SY, Baek SY, Park HT: Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo. Glia. 2009, 57: 1825-1834. 10.1002/glia.20894.PubMed

50.

Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA: Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci. 2005, 25: 3478-3487. 10.1523/JNEUROSCI.3766-04.2005.PubMed

51.

Liu HM, Yang LH, Yang YJ: Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol. 1995, 54: 487-496. 10.1097/00005072-199507000-00002.PubMed

52.

Murinson BB, Archer DR, Li Y, Griffin JW: Degeneration of myelinated efferent fibers prompts mitosis in Remak Schwann cells of uninjured C-fiber afferents. J Neurosci. 2005, 25: 1179-1187. 10.1523/JNEUROSCI.1372-04.2005.PubMed

53.

Trapp BD, Hauer P, Lemke G: Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J Neurosci. 1988, 8: 3515-3521.PubMed

54.

White FV, Toews AD, Goodrum JF, Novicki DL, Bouldin TW, Morell P: Lipid metabolism during early stages of Wallerian degeneration in the rat sciatic nerve. J Neurochem. 1989, 52: 1085-1092. 10.1111/j.1471-4159.1989.tb01851.x.PubMed

55.

Pellegrino RG, Politis MJ, Ritchie JM, Spencer PS: Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. J Neurocytol. 1986, 15: 17-28. 10.1007/BF02057901.PubMed

56.

Stoll G, Griffin JW, Li CY, Trapp BD: Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol. 1989, 18: 671-683. 10.1007/BF01187086.PubMed

57.

Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol. 2001, 1: 135-145. 10.1038/35100529.PubMed

58.

Vabulas RM, Ahmad-Nejad P, da CC, Miethke T, Kirschning CJ, Hacker H, Wagner H: Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001, 276: 31332-31339. 10.1074/jbc.M103217200.PubMed

59.

Kariko K, Ni H, Capodici J, Lamphier M, Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004, 279: 12542-12550.PubMed

60.

Brunn GJ, Bungum MK, Johnson GB, Platt JL: Conditional signaling by Toll-like receptor 4. FASEB J. 2005, 19: 872-874.PubMed

61.

Goethals S, Ydens E, Timmerman V, Janssens S: Toll-like receptor expression in the peripheral nerve. Glia. 2010, 58: 1701-1709. 10.1002/glia.21041.PubMed

62.

Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, Lee SJ: Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun. 2006, 350: 742-747. 10.1016/j.bbrc.2006.09.108.PubMed

63.

Karanth S, Yang G, Yeh J, Richardson PM: Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp Neurol. 2006, 202: 161-166. 10.1016/j.expneurol.2006.05.024.PubMed

64.

Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S: Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci. 2007, 27: 12565-12576. 10.1523/JNEUROSCI.3027-07.2007.PubMed

65.

Pineau I, Lacroix S: Endogenous signals initiating inflammation in the injured nervous system. Glia. 2009, 57: 351-361. 10.1002/glia.20763.PubMed

66.

Huang JK, Phillips GR, Roth AD, Pedraza L, Shan W, Belkaid W, Mi S, Fex-Svenningsen A, Florens L, Yates JR, Colman DR: Glial membranes at the node of Ranvier prevent neurite outgrowth. Science. 2005, 310: 1813-1817. 10.1126/science.1118313.PubMed

67.

Shen ZL, Lassner F, Bader A, Becker M, Walter GF, Berger A: Cellular activity of resident macrophages during Wallerian degeneration. Microsurgery. 2000, 20: 255-261. 10.1002/1098-2752(2000)20:5<255::AID-MICR6>3.0.CO;2-A.PubMed

68.

Meyer zu HG, Hu W, Hartung HP, Lehmann HC, Kieseier BC: The immunocompetence of Schwann cells. Muscle Nerve. 2008, 37: 3-13. 10.1002/mus.20893.

69.

Hirata K, Mitoma H, Ueno N, He JW, Kawabuchi M: Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J Neurocytol. 1999, 28: 685-695. 10.1023/A:1007012916530.PubMed

70.

Holtzman E, Novikoff AB: Lysomes in the rat sciatic nerve following crush. J Cell Biol. 1965, 27: 651-669. 10.1083/jcb.27.3.651.PubMedCentralPubMed

71.

Perry VH, Tsao JW, Fearn S, Brown MC: Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice. Eur J Neurosci. 1995, 7: 271-280. 10.1111/j.1460-9568.1995.tb01063.x.PubMed

72.

Martini R, Fischer S, Lopez-Vales R, David S: Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia. 2008, 56: 1566-1577. 10.1002/glia.20766.PubMed

73.

Ribardo DA, Crowe SE, Kuhl KR, Peterson JW, Chopra AK: Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D. J Biol Chem. 2001, 276: 5467-5475. 10.1074/jbc.M006690200.PubMed

74.

De S, Trigueros MA, Kalyvas A, David S: Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci. 2003, 24: 753-765. 10.1016/S1044-7431(03)00241-0.PubMed

75.

Shamash S, Reichert F, Rotshenker S: The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci. 2002, 22: 3052-3060.PubMed

76.

Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M: Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord. 1996, 6: 105-114. 10.1016/0960-8966(95)00029-1.PubMed

77.

Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS: Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem. 1995, 64: 850-858.PubMed

78.

Bourde O, Kiefer R, Toyka KV, Hartung HP: Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol. 1996, 69: 135-140.PubMed

79.

Banner LR, Patterson PH: Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Natl Acad Sci USA. 1994, 91: 7109-7113. 10.1073/pnas.91.15.7109.PubMedCentralPubMed

80.

Tofaris GK, Patterson PH, Jessen KR, Mirsky R: Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci. 2002, 22: 6696-6703.PubMed

81.

Subang MC, Richardson PM: Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue. Eur J Neurosci. 2001, 13: 521-528. 10.1046/j.1460-9568.2001.01425.x.PubMed

82.

Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR: TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci. 2006, 31: 407-415. 10.1016/j.mcn.2005.10.011.PubMedCentralPubMed

83.

Chen ZL, Yu WM, Strickland S: Peripheral regeneration. Annu Rev Neurosci. 2007, 30: 209-233. 10.1146/annurev.neuro.30.051606.094337.PubMed

84.

Patton BL, Miner JH, Chiu AY, Sanes JR: Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol. 1997, 139: 1507-1521. 10.1083/jcb.139.6.1507.PubMedCentralPubMed

85.

Wallquist W, Patarroyo M, Thams S, Carlstedt T, Stark B, Cullheim S, Hammarberg H: Laminin chains in rat and human peripheral nerve: distribution and regulation during development and after axonal injury. J Comp Neurol. 2002, 454: 284-293. 10.1002/cne.10434.PubMed

86.

Chen ZL, Strickland S: Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol. 2003, 163: 889-899. 10.1083/jcb.200307068.PubMedCentralPubMed

87.

Colognato H, ffrench-Constant C, Feltri ML: Human diseases reveal novel roles for neural laminins. Trends Neurosci. 2005, 28: 480-486. 10.1016/j.tins.2005.07.004.PubMed

88.

Gardiner NJ, Fernyhough P, Tomlinson DR, Mayer U, von der MH, Streuli CH: Alpha7 integrin mediates neurite outgrowth of distinct populations of adult sensory neurons. Mol Cell Neurosci. 2005, 28: 229-240. 10.1016/j.mcn.2004.08.017.PubMed

89.

Nodari A, Previtali SC, Dati G, Occhi S, Court FA, Colombelli C, Zambroni D, Dina G, Del CU, Campbell KP, Quattrini A, Wrabetz L, Feltri ML: Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci. 2008, 28: 6714-6719. 10.1523/JNEUROSCI.0326-08.2008.PubMedCentralPubMed

90.

Murphy PG, Grondin J, Altares M, Richardson PM: Induction of interleukin-6 in axotomized sensory neurons. J Neurosci. 1995, 15: 5130-5138.PubMed

91.

Cafferty WB, Gardiner NJ, Das P, Qiu J, McMahon SB, Thompson SW: Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci. 2004, 24: 4432-4443. 10.1523/JNEUROSCI.2245-02.2004.PubMed

92.

Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, Filbin MT: The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci. 2006, 26: 5565-5573. 10.1523/JNEUROSCI.0815-06.2006.PubMed

93.

Heumann R, Lindholm D, Bandtlow C, Meyer M, Radeke MJ, Misko TP, Shooter E, Thoenen H: Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci USA. 1987, 84: 8735-8739. 10.1073/pnas.84.23.8735.PubMedCentralPubMed

94.

Snider WD, Zhou FQ, Zhong J, Markus A: Signaling the pathway to regeneration. Neuron. 2002, 35: 13-16. 10.1016/S0896-6273(02)00762-6.PubMed

95.

Markus A, Patel TD, Snider WD: Neurotrophic factors and axonal growth. Curr Opin Neurobiol. 2002, 12: 523-531. 10.1016/S0959-4388(02)00372-0.PubMed

96.

Fu SY, Gordon T: The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol. 1997, 14: 67-116. 10.1007/BF02740621.PubMed

97.

Scott AL, Ramer MS: Schwann cell p75NTR prevents spontaneous sensory reinnervation of the adult spinal cord. Brain. 2010, 133: 421-432. 10.1093/brain/awp316.PubMed

98.

Diamond J, Foerster A, Holmes M, Coughlin M: Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J Neurosci. 1992, 12: 1467-1476.PubMed

99.

Diamond J, Coughlin M, Macintyre L, Holmes M, Visheau B: Evidence that endogenous beta nerve growth factor is responsible for the collateral sprouting, but not the regeneration, of nociceptive axons in adult rats. Proc Natl Acad Sci USA. 1987, 84: 6596-6600. 10.1073/pnas.84.18.6596.PubMedCentralPubMed

100.

Mahanthappa NK, Anton ES, Matthew WD: Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. J Neurosci. 1996, 16: 4673-4683.PubMed

101.

Fricker FR, Lago N, Balarajah S, Tsantoulas C, Tanna S, Zhu N, Fageiry SK, Jenkins M, Garratt AN, Birchmeier C, Bennett DL: Axonally derived Neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood. J Neurosci. 2011, 31: 3225-3233. 10.1523/JNEUROSCI.2568-10.2011.PubMedCentralPubMed

102.

103.

Sulaiman OA, Gordon T: Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia. 2000, 32: 234-246. 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3.PubMed

104.

Dedkov EI, Kostrominova TY, Borisov AB, Carlson BM: Survival of Schwann cells in chronically denervated skeletal muscles. Acta Neuropathol. 2002, 103: 565-574. 10.1007/s00401-001-0504-6.PubMed

105.

Sulaiman OA, Gordon T: Transforming growth factor-beta and forskolin attenuate the adverse effects of long-term Schwann cell denervation on peripheral nerve regeneration in vivo. Glia. 2002, 37: 206-218. 10.1002/glia.10022.PubMed

106.

Li H, Terenghi G, Hall SM: Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia. 1997, 20: 333-347. 10.1002/(SICI)1098-1136(199708)20:4<333::AID-GLIA6>3.0.CO;2-6.PubMed

107.

Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006, 6: 173-182. 10.1038/nri1785.PubMed

108.

Perkins NM, Tracey DJ: Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience. 2000, 101: 745-757. 10.1016/S0306-4522(00)00396-1.PubMed

109.

Kennedy AD, DeLeo FR: Neutrophil apoptosis and the resolution of infection. Immunol Res. 2009, 43: 25-61. 10.1007/s12026-008-8049-6.PubMed

110.

Mueller M, Leonhard C, Wacker K, Ringelstein EB, Okabe M, Hickey WF, Kiefer R: Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab Invest. 2003, 83: 175-185.PubMed

111.

Perry VH, Brown MC, Gordon S: The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med. 1987, 165: 1218-1223. 10.1084/jem.165.4.1218.PubMed

112.

Vass K, Hickey WF, Schmidt RE, Lassmann H: Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest. 1993, 69: 275-282.PubMed

113.

Bruck W, Friede RL: The role of complement in myelin phagocytosis during PNS wallerian degeneration. J Neurol Sci. 1991, 103: 182-187. 10.1016/0022-510X(91)90162-Z.PubMed

114.

Bonnekoh PG, Scheidt P, Friede RL: Myelin phagocytosis by peritoneal macrophages in organ cultures of mouse peripheral nerve. A new model for studying myelin phagocytosis in vitro. J Neuropathol Exp Neurol. 1989, 48: 140-153. 10.1097/00005072-198903000-00002.PubMed

115.

Mueller M, Wacker K, Ringelstein EB, Hickey WF, Imai Y, Kiefer R: Rapid response of identified resident endoneurial macrophages to nerve injury. Am J Pathol. 2001, 159: 2187-2197. 10.1016/S0002-9440(10)63070-2.PubMedCentralPubMed

116.

Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W: The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol. 2000, 110: 177-185. 10.1016/S0165-5728(00)00343-X.PubMed

117.

Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA: Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci USA. 2010, 107: 11993-11998. 10.1073/pnas.1001948107.PubMedCentralPubMed

118.

Liu L, Lioudyno M, Tao R, Eriksson P, Svensson M, Aldskogius H: Hereditary absence of complement C5 in adult mice influences Wallerian degeneration, but not retrograde responses, following injury to peripheral nerve. J Peripher Nerv Syst. 1999, 4: 123-133.PubMed

119.

Bouldin TW, Earnhardt TS, Goines ND: Restoration of blood-nerve barrier in neuropathy is associated with axonal regeneration and remyelination. J Neuropathol Exp Neurol. 1991, 50: 719-728. 10.1097/00005072-199111000-00004.PubMed

120.

Bruck W, Friede RL: Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 1990, 80: 415-418. 10.1007/BF00307696.PubMed

121.

Bruck W: The role of macrophages in Wallerian degeneration. Brain Pathol. 1997, 7: 741-752. 10.1111/j.1750-3639.1997.tb01060.x.PubMed

122.

Gaudet AD, Leung M, Poirier F, Kadoya T, Horie H, Ramer MS: A role for galectin-1 in the immune response to peripheral nerve injury. Exp Neurol. 2009, 220: 320-327. 10.1016/j.expneurol.2009.09.007.PubMed

123.

Malik RK, Ghurye RR, Lawrence-Watt DJ, Stewart HJ: Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway. Glycobiology. 2009, 19: 1402-1407. 10.1093/glycob/cwp077.PubMed

124.

Horie H, Kadoya T, Hikawa N, Sango K, Inoue H, Takeshita K, Asawa R, Hiroi T, Sato M, Yoshioka T, Ishikawa Y: Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J Neurosci. 2004, 24: 1873-1880. 10.1523/JNEUROSCI.4483-03.2004.PubMed

125.

Gaudet AD, Steeves JD, Tetzlaff W, Ramer MS: Expression and functions of galectin-1 in sensory and motoneurons. Curr Drug Targets. 2005, 6: 419-425. 10.2174/1389450054021864.PubMed

126.

Horie H, Inagaki Y, Sohma Y, Nozawa R, Okawa K, Hasegawa M, Muramatsu N, Kawano H, Horie M, Koyama H, Sakai I, Takeshita K, Kowada Y, Takano M, Kadoya T: Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy. J Neurosci. 1999, 19: 9964-9974.PubMed

127.

McGraw J, McPhail LT, Oschipok LW, Horie H, Poirier F, Steeves JD, Ramer MS, Tetzlaff W: Galectin-1 in regenerating motoneurons. Eur J Neurosci. 2004, 20: 2872-2880. 10.1111/j.1460-9568.2004.03802.x.PubMed

128.

Beuche W, Friede RL: The role of non-resident cells in Wallerian degeneration. J Neurocytol. 1984, 13: 767-796. 10.1007/BF01148493.PubMed

129.

Bruck W, Huitinga I, Dijkstra CD: Liposome-mediated monocyte depletion during wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J Neurosci Res. 1996, 46: 477-484. 10.1002/(SICI)1097-4547(19961115)46:4<477::AID-JNR9>3.0.CO;2-D.PubMed

130.

La Fleur M, Underwood JL, Rappolee DA, Werb Z: Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med. 1996, 184: 2311-2326. 10.1084/jem.184.6.2311.PubMed

131.

Hikawa N, Takenaka T: Myelin-stimulated macrophages release neurotrophic factors for adult dorsal root ganglion neurons in culture. Cell Mol Neurobiol. 1996, 16: 517-528. 10.1007/BF02150231.PubMed

132.

Luk HW, Noble LJ, Werb Z: Macrophages contribute to the maintenance of stable regenerating neurites following peripheral nerve injury. J Neurosci Res. 2003, 73: 644-658. 10.1002/jnr.10701.PubMedCentralPubMed

133.

Kuhlmann T, Bitsch A, Stadelmann C, Siebert H, Bruck W: Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci. 2001, 21: 3401-3408.PubMed

134.

Fry EJ, Ho C, David S: A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron. 2007, 53: 649-662. 10.1016/j.neuron.2007.02.009.PubMed

135.

Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S: Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation. 2011, 8: 24-10.1186/1742-2094-8-24.PubMedCentralPubMed

136.

Moalem G, Xu K, Yu L: T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience. 2004, 129: 767-777. 10.1016/j.neuroscience.2004.08.035.PubMed

137.

Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986, 136: 2348-2357.PubMed

138.

London CA, Abbas AK, Kelso A: Helper T cell subsets: heterogeneity, functions and development. Vet Immunol Immunopathol. 1998, 63: 37-44. 10.1016/S0165-2427(98)00080-4.PubMed

139.

Xin J, Wainwright DA, Mesnard NA, Serpe CJ, Sanders VM, Jones KJ: IL-10 within the CNS is necessary for CD4(+) T cells to mediate neuroprotection. Brain Behav Immun. 2011, 25: 820-829. 10.1016/j.bbi.2010.08.004.PubMedCentralPubMed

140.

Beahrs T, Tanzer L, Sanders VM, Jones KJ: Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice. Exp Neurol. 2010, 221: 225-230. 10.1016/j.expneurol.2009.11.003.PubMedCentralPubMed

141.

Barrette B, Hebert MA, Filali M, Lafortune K, Vallieres N, Gowing G, Julien JP, Lacroix S: Requirement of myeloid cells for axon regeneration. J Neurosci. 2008, 28: 9363-9376. 10.1523/JNEUROSCI.1447-08.2008.PubMed

142.

Lu X, Richardson PM: Inflammation near the nerve cell body enhances axonal regeneration. J Neurosci. 1991, 11: 972-978.PubMed

143.

Whetstone WD, Hsu JY, Eisenberg M, Werb Z, Noble-Haeusslein LJ: Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J Neurosci Res. 2003, 74: 227-239. 10.1002/jnr.10759.PubMedCentralPubMed

144.

Fawcett JW: Overcoming inhibition in the damaged spinal cord. J Neurotrauma. 2006, 23: 371-383. 10.1089/neu.2006.23.371.PubMed

145.

Yiu G, He Z: Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006, 7: 617-627.PubMedCentralPubMed

146.

Barres BA, Schmid R, Sendnter M, Raff MC: Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 1993, 118: 283-295.PubMed

147.

Casha S, Yu WR, Fehlings MG: Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience. 2001, 103: 203-218. 10.1016/S0306-4522(00)00538-8.PubMed

148.

Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997, 3: 73-76. 10.1038/nm0197-73.PubMed

149.

Almad A, Sahinkaya FR, McTigue DM: Oligodendrocyte fate after spinal cord injury. Neurotherapeutics. 2011, 8: 262-273. 10.1007/s13311-011-0033-5.PubMedCentralPubMed

150.

Dougherty KD, Dreyfus CF, Black IB: Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis. 2000, 7: 574-585. 10.1006/nbdi.2000.0318.PubMed

151.

Ludwin SK: Phagocytosis in the rat optic nerve following Wallerian degeneration. Acta Neuropathol. 1990, 80: 266-273. 10.1007/BF00294644.PubMed

152.

Vaughn JE, Pease DC: Electron microscopic studies of wallerian degeneration in rat optic nerves. II. Astrocytes, oligodendrocytes and adventitial cells. J Comp Neurol. 1970, 140: 207-226. 10.1002/cne.901400205.PubMed

153.

Davies SJ, Goucher DR, Doller C, Silver J: Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci. 1999, 19: 5810-5822.PubMed

154.

Hermanns S, Klapka N, Muller HW: The collagenous lesion scar--an obstacle for axonal regeneration in brain and spinal cord injury. Restor Neurol Neurosci. 2001, 19: 139-148.PubMed

155.

Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009, 29: 13435-13444. 10.1523/JNEUROSCI.3257-09.2009.PubMedCentralPubMed

156.

Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008, 8: 958-969. 10.1038/nri2448.PubMedCentralPubMed

157.

Laskin DL: Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol. 2009, 22: 1376-1385. 10.1021/tx900086v.PubMedCentralPubMed

158.

Sica A, Schioppa T, Mantovani A, Allavena P: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006, 42: 717-727. 10.1016/j.ejca.2006.01.003.PubMed

159.

Gensel JC, Nakamura S, Guan Z, van Rooijen N, Ankeny DP, Popovich PG: Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci. 2009, 29: 3956-3968. 10.1523/JNEUROSCI.3992-08.2009.PubMedCentralPubMed

160.

Becerra JL, Puckett WR, Hiester ED, Quencer RM, Marcillo AE, Post MJ, Bunge RP: MR-pathologic comparisons of wallerian degeneration in spinal cord injury. AJNR Am J Neuroradiol. 1995, 16: 125-133.PubMed

161.

Buss A, Brook GA, Kakulas B, Martin D, Franzen R, Schoenen J, Noth J, Schmitt AB: Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain. 2004, 127: 34-44. 10.1093/brain/awh001.PubMed

162.

Vallieres N, Berard JL, David S, Lacroix S: Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia. 2006, 53: 103-113. 10.1002/glia.20266.PubMed

163.

Gladson CL: The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol. 1999, 58: 1029-1040. 10.1097/00005072-199910000-00001.PubMed

164.

Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG: Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol. 2004, 36: 1046-1069. 10.1016/j.biocel.2004.01.013.PubMed

165.

McKeon RJ, Schreiber RC, Rudge JS, Silver J: Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci. 1991, 11: 3398-3411.PubMed

166.

Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000, 403: 434-439. 10.1038/35000219.PubMed

167.

GrandPre T, Nakamura F, Vartanian T, Strittmatter SM: Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 2000, 403: 439-444. 10.1038/35000226.PubMed

168.

Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M: Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci USA. 2005, 102: 1205-1210. 10.1073/pnas.0409026102.PubMedCentralPubMed

169.

Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, Kang B, Zheng B: Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron. 2010, 66: 663-670. 10.1016/j.neuron.2010.05.002.PubMedCentralPubMed

170.

Lee JK, Chow R, Xie F, Chow SY, Tolentino KE, Zheng B: Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. J Neurosci. 2010, 30: 10899-10904. 10.1523/JNEUROSCI.2269-10.2010.PubMedCentralPubMed

Title: Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury
Authors: Andrew D Gaudet
Phillip G Popovich
Matt S Ramer
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/1742-2094-8-110

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior

Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment

Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation

The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis

Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice

Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage